These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12406838)

  • 81. Aerosolized antimicrobials: another look.
    Itokazu GS; Weinstein RA
    Crit Care Med; 1998 Jan; 26(1):5-6. PubMed ID: 9428531
    [No Abstract]   [Full Text] [Related]  

  • 82. A bovine model of a respiratory Parachlamydia acanthamoebae infection.
    Lohr M; Prohl A; Ostermann C; Liebler-Tenorio E; Schroedl W; Aeby S; Greub G; Reinhold P
    Pathog Dis; 2015 Feb; 73(1):1-14. PubMed ID: 24989139
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lung Ultrasound and Microbubbles Enhance Aminoglycoside Efficacy and Delivery to the Lung in Escherichia coli-induced Pneumonia and Acute Respiratory Distress Syndrome.
    Sugiyama MG; Mintsopoulos V; Raheel H; Goldenberg NM; Batt JE; Brochard L; Kuebler WM; Leong-Poi H; Karshafian R; Lee WL
    Am J Respir Crit Care Med; 2018 Aug; 198(3):404-408. PubMed ID: 29638143
    [No Abstract]   [Full Text] [Related]  

  • 84. Influence of Tracheostomy on Lung Deposition in Spontaneously Breathing Patients.
    Pitance L; Reychler G; Vecellio L; Leal T; Reychler H; Liistro G
    J Aerosol Med Pulm Drug Deliv; 2016 Oct; 29(5):454-460. PubMed ID: 26907544
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Status Update on Pharmaceutical Analytical Methods of Aminoglycoside Antibiotic: Amikacin.
    Raut A; Sharma D; Suvarna V
    Crit Rev Anal Chem; 2022; 52(2):375-391. PubMed ID: 32781828
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Infected chylothorax caused by Escherichia coli in a non- immunocompromised child.
    Biswas A; Ghosh JK; Chatterjee A; Basu K; Chatterjee S
    Indian J Pediatr; 2008 Feb; 75(2):192-3. PubMed ID: 18334806
    [No Abstract]   [Full Text] [Related]  

  • 87. Comment on: Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
    Cooreman S; Jeurissen A
    J Antimicrob Chemother; 2011 May; 66(5):1197-8; author reply 1198-9. PubMed ID: 21131691
    [No Abstract]   [Full Text] [Related]  

  • 88. Nebulized Versus IV Amikacin: Systemic Antibiotics Treatment Modalities May Hamper Results.
    Jacobs FM
    Crit Care Med; 2018 Jul; 46(7):e732. PubMed ID: 29912134
    [No Abstract]   [Full Text] [Related]  

  • 89. When will nebulized chemotherapy come of age?
    Mukhopadhyay S
    Respir Med; 1994 Apr; 88(4):245-7. PubMed ID: 8036286
    [No Abstract]   [Full Text] [Related]  

  • 90. Terminal bronchopneumonia. A bacteriological and histological study of 111 necropsies.
    Tanner EI; Gray JD; Rebello PV; Gamble DR
    J Hyg (Lond); 1969 Sep; 67(3):477-84. PubMed ID: 4897543
    [No Abstract]   [Full Text] [Related]  

  • 91. Enhanced Amikacin Diffusion With Ultrasound and Microbubbles in a Mechanically Ventilated Condensed Lung Rabbit Model.
    Espitalier F; Darrouzain F; Escoffre JM; Ternant D; Piver E; Bouakaz A; Remerand F
    Front Pharmacol; 2019; 10():1562. PubMed ID: 32009963
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tree-in-bud sign.
    Santra G
    J Assoc Physicians India; 2010 May; 58():315. PubMed ID: 21117351
    [No Abstract]   [Full Text] [Related]  

  • 93. Reagent-free determination of amikacin content in amikacin sulfate injections by FTIR derivative spectroscopy in a continuous flow system.
    Ovalles JF; Gallignani M; Brunetto MR; Rondón RA; Ayala C
    J Pharm Anal; 2014 Apr; 4(2):125-131. PubMed ID: 29403874
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The INHALE trial: multiple reasons for a negative result.
    Rouby JJ; Monsel A; Ehrmann S; Bouglé A; Laterre PF
    Lancet Infect Dis; 2020 Jul; 20(7):778-779. PubMed ID: 32592666
    [No Abstract]   [Full Text] [Related]  

  • 95. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Yang J; Liu Z; Gutierrez C; Aymard G; Rouby JJ;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):106-15. PubMed ID: 21474643
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies.
    Rouby JJ; Bouhemad B; Monsel A; Brisson H; Arbelot C; Lu Q;
    Anesthesiology; 2012 Dec; 117(6):1364-80. PubMed ID: 23135264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.
    Luyt CE; Clavel M; Guntupalli K; Johannigman J; Kennedy JI; Wood C; Corkery K; Gribben D; Chastre J
    Crit Care; 2009; 13(6):R200. PubMed ID: 20003269
    [TBL] [Abstract][Full Text] [Related]  

  • 98. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.
    Niederman MS; Chastre J; Corkery K; Fink JB; Luyt CE; García MS
    Intensive Care Med; 2012 Feb; 38(2):263-71. PubMed ID: 22147112
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
    Niederman MS; Alder J; Bassetti M; Boateng F; Cao B; Corkery K; Dhand R; Kaye KS; Lawatscheck R; McLeroth P; Nicolau DP; Wang C; Wood GC; Wunderink RG; Chastre J
    Lancet Infect Dis; 2020 Mar; 20(3):330-340. PubMed ID: 31866328
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis.
    Xu F; He LL; Che LQ; Li W; Ying SM; Chen ZH; Shen HH
    Crit Care; 2018 Nov; 22(1):301. PubMed ID: 30442203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.